Catalyst Funds Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$9.8M |
| 2 |
Amphenol
APH
|
+$6.39M |
| 3 |
Applovin
APP
|
+$5.63M |
| 4 |
CRH
CRH
|
+$3.85M |
| 5 |
Insmed
INSM
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rio Tinto
RIO
|
+$11.7M |
| 2 |
Pfizer
PFE
|
+$7.17M |
| 3 |
NVIDIA
NVDA
|
+$7.15M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$7.02M |
| 5 |
Mastercard
MA
|
+$5.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Financials | 14.89% |
| 3 | Industrials | 12.22% |
| 4 | Materials | 11.64% |
| 5 | Healthcare | 9.91% |
Similar funds
Catalyst Funds Management's Q2 2025 Portfolio in Review
As of Q2 2025, Catalyst Funds Management held 737 positions worth $362M, down 5.3% from $382M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Catalyst Funds Management withdrew a net $61.6M in Q2 2025, closing 308 positions and reducing 94 holdings. Its most notable exit was Pfizer, an estimated $7.17M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
Against the trend, Catalyst Funds Management opened a new position in VanEck Gold Miners ETF worth $10.3M.
- Catalyst Funds Management's largest Q2 2025 buy was VanEck Gold Miners ETF: 197,400 shares worth $10.3M.
- Catalyst Funds Management added most to Applovin in Q2 2025, an estimated $5.63M increase.
- Catalyst Funds Management's biggest Q2 2025 reduction was Rio Tinto, cutting an estimated $11.7M.
- Catalyst Funds Management fully exited Pfizer in Q2 2025, selling an estimated $7.17M.
- Catalyst Funds Management's ten largest holdings make up 19% of its $362M portfolio in Q2 2025.
- Catalyst Funds Management opened 289 new positions and closed 308 in Q2 2025.
- Catalyst Funds Management's portfolio value fell 5.3% quarter-over-quarter to $362M.
Based on Catalyst Funds Management's 13F filing for Q2 2025, filed 12 Aug 2025.